PO.PR02.02 · 预防研究

一种罕见的多能钉状(peg-like)上皮细胞是高级别浆液性卵巢癌的候选起源细胞

A rare multipotent peg-like epithelial cell is a candidate cell-of-origin for high-grade serous ovarian cancer

编号 7636 展板 23 时间 4/22 09:00–12:00 区域 Section 36 主讲 Megan Ritting, BS
分会场 Cancer and Cancer Related Alterations, Detection Approaches, and Molecular Characterization
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Megan L. Ritting1, Wenmei Yang2, Syed Mohammed Musheer Aalam2, Hui Zhao2, Liang Feng2, Jianning Song2, Mihai G. Dumbrava1, Wazim M. Ismail3, Kenneth Schaufelberger2, S. John Weroha4, Scott H. Kaufmann5, Alexandre Gaspar-Maia3, Mark E. Sherman6, Jamie N. Bakkum-Gamez7, Nagarajan Kannan2

1Mayo Clinic College of Medicine and Science, Rochester, MN,2Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN,3Center for Individualized Medicine, Mayo Clinic, Rochester, MN,4Department of Medical Oncology, Mayo Clinic, Rochester, MN,5Department of Oncology, Mayo Clinic, Rochester, MN,6Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL,7Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN

摘要 Abstract

中文摘要
高级别浆液性卵巢癌(HGSOC)是最常见且最致命的卵巢癌亚型,由于缺乏有效的早期检测策略,通常在晚期才被诊断。越来越多的证据表明,HGSOC起源于输卵管(FT),尤其是伞端的分泌上皮细胞。然而,对HGSOC细胞和分子起源的认识不足仍在阻碍早期拦截的努力。为解决这一问题,我们在Mayo Clinic建立了一个具有临床和遗传学注释的活体FT类器官生物库,代表了200余名患者供者。采用优化的富集方案,我们从组织和Tao刷检样本中分离FT上皮干/祖细胞,生成不依赖解剖部位或侧别的类器官,这些类器官重现了天然FT上皮结构和谱系分化。我们对新鲜细胞和类器官进行了整合的多组学分析,包括单细胞RNA测序、单核RNA/ATAC测序和bulk RNA-seq。与公共数据集整合,产生了迄今为止最大的正常及高风险FT单细胞图谱。该分析界定了针对分泌谱系和多纤毛谱系的高特异性基因特征,其表现优于经典谱系标志物(如PAX8、FOXJ1),鉴定了谱系决定性转录因子和调控网络,并显示在人FT上皮中蛋白表达一致。值得注意的是,亚簇水平分析揭示了一个罕见的上皮-间充质杂合群体,其在转录组和蛋白质组上与HGSOC的间充质样亚型一致。空间免疫分析表明,这些细胞表达多个决定性标志物,位于基底膜之上、嵌插于上皮细胞之间且缺乏管腔接触,令人联想到组织学上描述的钉状(peg)细胞群体。与胎儿中肾组织的比较分析揭示了发育上的相似性,且该群体在3D类器官培养中稳定维持,提供了一个研究早期转化的稳健离体模型。总之,我们的发现将一个具有间充质特征的罕见多能上皮群体确定为间充质样HGSOC的候选起源,并将FT类器官生物库确立为卵巢癌发生机制研究和转化研究的有力平台。
查看英文原文 English abstract
High-grade serous ovarian cancer (HGSOC), the most prevalent and lethal ovarian cancer subtype, is typically diagnosed at an advanced stage due to the absence of effective early detection strategies. Mounting evidence indicates that HGSOC originates from the fallopian tube (FT), particularly from secretory epithelial cells in the fimbria. However, incomplete understanding of the cellular and molecular origins of HGSOC continues to hinder early interception efforts. To address this, we established a clinically and genetically annotated living FT organoid biobank at Mayo Clinic, representing over 200 patient donors. Using optimized enrichment protocols, we isolated FT epithelial stem/progenitor cells from tissue and Tao brushings, generating organoids independent of anatomical site or laterality that recapitulate native FT epithelial architecture and lineage differentiation. We applied integrated multi-omic analyses, including single-cell RNA sequencing, single-nucleus RNA/ATAC sequencing, and bulk RNA-seq, across fresh cells and organoids. Integration with public datasets produced the largest single-cell atlas of normal and high-risk FTs to date. This analysis defined high-specificity gene signatures for secretory and multiciliated lineages that outperform canonical lineage markers (e.g. PAX8, FOXJ1 ), identified lineage-defining transcription factors and regulatory networks, and showed concordant protein expression in the human FT epithelium. Notably, subcluster-level analysis revealed a rare hybrid epithelial-mesenchymal population transcriptionally and proteomically aligned with the mesenchymal-like subtype of HGSOC. Spatial immunoprofiling demonstrated that these cells express multiple defining markers and reside above the basement membrane, intercalated between epithelial cells and lack luminal contact, reminiscent of the histologically described peg cell population. Comparative analyses with fetal mesonephric tissues uncovered developmental parallels, and this population was stably maintained in 3D organoid cultures, providing a robust ex-vivo model to study early transformation. Together, our findings identify a rare, multipotent epithelial population with mesenchymal features as a candidate origin for mesenchymal-like HGSOC and establish the FT organoid biobank as a powerful platform for mechanistic and translational studies in ovarian carcinogenesis.
利益披露 Disclosure
M. L. Ritting, None.. W. Yang, None.. S. Aalam, None.. H. Zhao, None.. L. Feng, None.. J. Song, None.. M. G. Dumbrava, None.. W. M. Ismail, None.. K. Schaufelberger, None.. S. Weroha, None.. S. H. Kaufmann, None.. A. Gaspar-Maia, None. M. E. Sherman, Exact Sciences ). J. N. Bakkum-Gamez, Exact Sciences ), Other Intellectual Property. UpToDate Other, Honoraria. Elsevier Other, Honoraria. N. Kannan, None.

← 返回 AACR 2026 检索